Page last updated: 2024-11-05

thalidomide and Pulmonary Aspergillosis

thalidomide has been researched along with Pulmonary Aspergillosis in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Pulmonary Aspergillosis: Infections of the respiratory tract with fungi of the genus ASPERGILLUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawai, T1
Watanabe, N1
Yokoyama, M1
Arai, K1
Oana, S1
Harayama, S1
Yasui, K1
Oh-Ishi, T1
Onodera, M1

Other Studies

1 other study available for thalidomide and Pulmonary Aspergillosis

ArticleYear
Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease.
    Clinical immunology (Orlando, Fla.), 2013, Volume: 147, Issue:2

    Topics: Adenosine Triphosphate; Caspase 1; Cells, Cultured; Child, Preschool; Cytokines; Granulomatous Disea

2013